The tracheal tube and airway products market is set to reach from US$ 3,578.5 Mn in 2020 to US$ 6,414.0 Mn by 2029 at a compound annual growth rate (CAGR) of 6.8% during the forecast period from 2021 to 2029. As per the research citing published by World Health Organization (WHO), approximately 90% of the death occurring due to chronic obstructive pulmonary disease (COPD) is occurring in the lower and middle income countries.
"Significant rise in surgical procedures and flexibility to deliver medications drives the endotracheal tubes market demand"
Endotracheal tube is the largest product segment in the tracheal tube and airway products market. Significant rise in the number of surgical procedures requiring anesthesia and is flexible in delivering medications in unconscious patients. Laryngeal mask is gaining tremendous traction on account of its availability in different configurations such as LMA flexible, Proseal, Supreme, CTrach etc. It also serves as an alternative to mask anesthesia and short surgical procedures which do not require endotracheal tubes.
"Rising public health awareness and availability of intensive care units together drive the hospitals market growth"
Hospitals are dominating the end user segment for tracheal tube and airway products market. The important parameters responsible for its outstanding growth are rising public health awareness resulting in significant rise of inpatient visits and availability of intensive care units well equipped with airway products. Ambulatory surgical centers are gaining tremendous traction owing to its ability to provide emergency medical intervention to patients suffering from pulmonary trauma in remote regions.
"Rising prevalence of pulmonary disorders and existence of major players together drive the market growth in North America region"
North America is spearheading the regional segment for tracheal tube and airway products market accounting for a share of 35.1% market share. The key factors promoting its supreme market growth are rising prevalence of pulmonary disorder. As per the statistics brought forward by the Center for Disease Control and Prevention (CDC), the number of deaths related to chronic lower respiratory diseases is 49.2 per 100,000 people. It is considered as the 4th largest cause of death in the United States. The presence of key players such as Medline, Industries, Inc., Medtronic, Plc. Teleflex Incorporated, Smiths Medical etc. further bolster the market growth in the region. Europe is holding 30.6% market share owing to the supportive regulatory environment provided by the European Medical Agency (EMA) regarding the sale of tracheal tube and airway products. Asia Pacific is representing 16.8% market share on account of rising incidence of chronic obstructive pulmonary disease, increased consumption of tobacco and smoking. Growing urbanization and industrialization causes air pollution which is an important risk factor associated with chronic lower respiratory diseases.
Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Tracheal Tube and Airway Products market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
End User |
Region Segment (2020–2030; US$ Million)
Global Impact of Covid-19 Segment (2020-2021; US$ Million )
Key questions answered in this report